Eiichi Nakayama

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Shin Onizuka, Isao Tawara, Jun Shimizu et al. · PubMed · 1999 · 1.1K citations

Immunology, Immune Regulation, Pathology +22

Immune-mediated antitumor effect by type 2 diabetes drug, metformin

Shingo Eikawa, Mikako Nishida, Shusaku Mizukami et al. · Proceedings of the National Academy of Sciences · 2015 · 522 citations · Full text

Immunology, Immune Regulation, Immunoediting +27

Fcα/μ receptor mediates endocytosis of IgM-coated microbes

Akira Shibuya, Norihisa Sakamoto, Yoshio Shimizu et al. · Nature Immunology · 2000 · 378 citations

Fcα/μ Receptor, Pathogenesis, Immunology +7

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Yoshihiro Watanabe, Kagemasa Kuribayashi, Shin‐Ichi Miyatake et al. · Proceedings of the National Academy of Sciences · 1989 · 284 citations · Full text

Immunology, Immunoediting, Immunologic Mechanism +17

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Koji Kurose, Yoshihiro Ohue, Hisashi Wada et al. · Clinical Cancer Research · 2015 · 249 citations